Survey of resistance to chloroquine by Plasmodium vivax in Indonesia

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 4, 1996, Pages 409-411

  Baird, J K ^a,d   Sustriayu Nalim, M F ^b   Basri, H ^a   Masbar, S ^a   Leksana, B ^a   Tjitra, E ^b   Dewi, R M ^b   Khairani, M ^c   Wignall, F S ^a  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^b Natl Inst of Hlth Res/Devmt   (Indonesia)

^c Central Health Clinic   (Indonesia)

^d NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Chloroquine resistance; Indonesia; Malaria; Plasmodium vivax

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SMEAR; CHILD; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; INDIAN OCEAN; INDONESIA; MALARIA; MALE; PLASMODIUM VIVAX; SYMPTOM;

PLASMODIUM VIVAX;

EID: 16044366588     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90526-X     Document Type: Short Survey

References (25)

1. Alving, A. S., Craige, B., jr, Jones, R., jr, Whorton, C. M., Pullman, T. N. & Eichelberger L. (1948). Pentaquine, a therapeutic agent effective in reducing the relapse rate in vivax malaria. Journal of Clinical Investigation, 27 supplement 2, 25-33.
2. Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C. & Hoffman, S. L. (1991). Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 44, 547-552.
3. Baird, J. K., Fryauff, D. J., Basri, H., Bangs, M. J., Subianto, B., Wiady, I., Purnomo, Leksana, B., Masbar, S., Richie, T. L., Jones, T. R., Tjitra, E., Wignall, F. S. & Hoffman, S. L. (1995a). Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 52, 479-484.
4. Baird, J. K., Basri, H., Subianto, B., Fryauff, D. J., McElroy, P. D., Leksana, B., Richie, T. L., Masbar, S., Wignall, F. S. & Hoffman, S. L. (1995b). Treatment of chloroquine resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. Journal of Infectious Diseases, 171, 1678-1682.
5. Baird, J. K., Caneta-Miguel, E., Masbar, S., Bustos, D. G., Abrenica, J. A., Layawen, A. V. O., Calulut, J. M., Leksana, B. & Wignall, F. S. (1996a). Resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90.
6. Baird, J. K., Sismadi, P., Masbar, S., Leksana, B., Sekartuti, Ramzan, A. & Tjitra, E. (1996b). Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90.
7. Berliner, R. W., Earle, D. P., jr, Taggart, J. V., Zubrod, C. H., Welch, W. J., Conan, N. J., Bauman, E., Scudder, S. T. & Shannon, J. A. (1948). Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. Journal of Clinical Investigation, 27, 98-107.
8. Coatney, C. R., Cooper, W. C. & Young, M. D. (1950). Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. Journal of the National Malaria Society, 9, 381-396.
9. Craige, B., jr, Alving, A. S., Jones, R., jr, Whorton, C. M., Pullman, T. N. & Eichelberger L. (1947). The Chesson strain of Plasmodium vivax malaria. II. Relationship between prepatent period, latent period and relapse rate. Journal of Infectious Diseases, 80, 228-236.
10. Fryauff, D. J., Baird, J. K., Basri, H., Sumawinata, I., Purnomo, Richie, T. L., Ohrt, C. K., Mouzin, E., Church, C. J., Richards, A. L., Subianto, B., Sandjaya, B., Wignall, F. S. & Hoffman, S. L. (1995). Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria in Indonesia. Lancet, 346, 1190-1193.
11. Looareesuwan, S., Harinasuta, T. & Chongsuphajaisiddhi, T. (1992). Drug resistant malaria with special reference to Thailand. Southeast Asian Journal of Tropical Medicine and Public Health, 23, 621-634.
12. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai & Myint-Oo (1995). Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 307-308.
13. Most, H., London, I. M., Kane, C. A., Lavietes, P. H., Schroeder, E. F. & Hayman, J. M., jr (1946). Chloroquine for treatment of acute attacks of vivax malaria. Journal of the American Medical Association, 131, 963-967.
14. Murphy, G. S., Basri, H., Purnomo, Andersen, E. M., Bangs, M. J., Mount, D. L., Gorden, J., Lal, A. A., Purwokusumo, A. R., Harjosuwarno, S., Sorensen, K. & Hoffman, S. L. (1993). Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet, 341, 96-100.
15. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye & Nwe-Nwe-Yin (1993). Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 687.
16. Patchen, L. C., Mount, D. L., Schwartz, I. K. & Churchill, F. C. (1983). Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography, 278, 81-89.
17. Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R. & White, N. J. (1994). Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Journal of Infectious Diseases, 169, 932-935.
18. Pullman, T. N., Craige, B., jr, Alving, A. S., Whorton, C. M., Jones, R., jr & Eichelberger, L. (1948). Comparison of chloroquine, quinacrine, and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria (Chesson strain). Journal of Clinical Investigation, 27, 46-50.
19. Rieckmann, K. H., Davis, D. R. & Hutton, D. C. (1989). Plasmodium vivax resistance to chloroquine? Lancet, ii, 1183-1184.
20. Rombo, L., Bergqvist, Y. & Hellgren, U. (1987). Chloroquine and desethylchloroquine concentrations during regular longterm malaria prophylaxis. Bulletin of the World Health Organization, 65, 879-883.
21. Schuurkamp, G. J., Spicer, P. E., Kereu, R. K., Bulongol, P. K. & Rieckmann, K. H. (1992). Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 121-122.
22. Schwartz, I. K., Lackritz, E. M. & Patchen, L. C. (1991). Chloroquine resistant Plasmodium vivax from Indonesia. New England Journal of Medicine, 324, 927.
23. Tan-ariya, P., Na-Bangchang, K., Tin, T., Limpaibul, L., Brockelman, C. R. & Karbwang, J. (1995). Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 426-429.
24. Whorton, C. M., Yount, E., jr, Jones, R., jr, Alving, A. S., Pullman, T. N., Craige, B., jr & Eichelberger, L. (1950). Studies in human malaria. The Chesson strain of Plasmodium vivax malaria. III. Clinical aspects. Journal of Infectious Diseases, 80, 237-249.
25. Wiselogle, F.Y. (editor) (1946). A Survey of Antimalarial Drugs: 1941-1945. Ann Arbor, Michigan: J. W. Edwards.